GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Contract Signed with ScandiNova

22 Jul 2014 07:00

RNS Number : 9237M
Advanced Oncotherapy PLC
22 July 2014
 



22 July2014

 

ADVANCED ONCOTHERAPY PLC

("Advanced Oncotherapy" or "the Company")

 

Contract Signed with ScandiNova Systems AB

 

Advanced Oncotherapy (AIM: AVO), the developer of the next generation of particle therapy using protons to treat cancer, announces that it has entered into a collaboration with industry leader ScandiNova Systems AB ("ScandiNova"). ScandiNova will develop the high energy systems that will power the unit of the proprietary LIGHT system which will create the proton beam.

 

ScandiNova was founded in 2001 to commercialise technical expertise in pulsed power applications including Radiotherapy, Radar, industrial X-ray and scientific accelerator systems. The company is located in Uppsala, Sweden and has established a global network of collaborations with highly skilled and experienced partners covering industry, academia and research organisations such as CERN in Europe, Lawrence Livermore and Brookhaven National Laboratories in the US.

ScandiNova specialises in the development of solid state controlled power systems which require about one third of the space and are 30% more efficient than those used in standard, older technology - synchrotrons.

Mikael Lindholm, Founder, Senior VP Sales & Marketing ScandiNova, commented: "We have been working with ADAM since 2007 and from the very start have seen the potential in the LIGHT technology which should deliver a superior proton therapy technology. Our Solid State Pulse Power products are widely used and are now installed in 28 different countries in Europe, Asia, Australia, and North and South America. For us, it is a privilege to be working with an organisation which could become the number one supplier of the next generation of proton therapy. "

 

Sanjeev Pandya, CEO of Avdanced Oncotherapy, added: "In our due diligence prior to the acquisition of the LIGHT technology, it became clear that there were already many world class partners involved in the development of the LIGHT programme. ScandiNova is one such partner and I am really pleased to be able to make this announcement. Advanced Oncotherapy is going to continue this relationship and ScandiNova will become a key partner and supplier in helping us develop our complete LIGHT system."

 

For further information contact:

 

Advanced Oncotherapy Plc

www.avoplc.com

Sanjeev Pandya (CEO)

Tel: +44 20 3617 8739

Westhouse Securities (Nomad & Joint Broker)

Tel: +44 20 7601 6100

Antonio Bossi / David Coaten

 

Beaufort Securities (Joint Broker)

 

Tel: +44 20 7382 8300

Saif Janjua / Jon Levinson

 

 

Walbrook PR (Financial PR & IR)

avo@walbrookpr.com

Anna Dunphy / Mike Wort

 

Tel: +44 20 7933 8780

 

About Advanced Oncotherapy Plc

 

Mission:

To facilitate the wider use of particle therapy with protons for treating all forms of cancerous tumours by commercialising novel technologies inspired by CERN and the Large Hadron Collider.

 

Key corporate messages:

AVO's team based at CERN near Geneva focuses on the development of a proprietary proton system called Linac Image Guided Hadron Technology (LIGHT). This LIGHT system accelerates protons to the energy levels achieved in legacy machines but in a unit that is a quarter of the size and between a quarter and a fifth of the cost. This compact configuration delivers proton beams in a way that facilitates a greater precision and electronic control which is not achievable with older technologies.

 

AVO is a provider of proton radiotherapy that harnesses the best in modern technology. As a result, the Company will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology which is proven to bring better health outcomes and lower treatment related side effects.

 

AVO continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships the Company will remain the prime provider of innovative and cost-effective equipment for proton radiation. This will allow healthcare suppliers to access more cost effective and more efficient ways to treat the increasing number of cancer patients who expect lower short term and long term side effects of their cancer care. 

For more information, please visit http://www.avoplc.com

 

About ScandiNova

 

ScandiNova Systems AB is a company based in Uppsala, Sweden. The company has an office in USA and representatives in 8 other countries. The company is growing continuously, since many customers in various applications are leaving the old traditional technology.

 

ScandiNova provides advanced high power Pulse Generators and fully integrated RF units, providing RF power up to 100MW and voltage pulses up to 500kV. The ScandiNova products are based on a unique patented Solid State parallel switching technology, which provides very high reliability and exceptional pulse quality and precision. Additionally, the power consumption is about 30% less than the traditional technology, which in high power applications is an important environmental requirement.

 

ScandiNova is supported by its main strong owners SEB Ventures (part of the biggest Swedish Bank SEB) and Industrifonden (the biggest government initiated fund).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTVFLFLZDFFBBQ
Date   Source Headline
1st Sep 20111:21 pmRNSDirectorate Change
31st Aug 20117:00 amRNSDisposal of German Property Portfolio
29th Jun 20117:30 amRNSStatement re. Suspension
27th Jan 20112:44 pmRNSHolding(s) in Company
13th Jan 20114:37 pmRNSHolding(s) in Company
5th Jan 20111:32 pmRNSDirectorate Change
6th Dec 20102:28 pmRNSChange of Adviser
18th Nov 20107:00 amRNSFinancial Close For Primary Care Project
16th Nov 20103:58 pmRNSHolding(s) in Company
27th Sep 20107:00 amRNSInterim Report - Six months to 30 June 2010
27th Jul 20105:12 pmRNSResult of AGM
30th Jun 20104:24 pmRNSFinal Results
30th Jun 20107:01 amRNSFormation of Proton Therapy Global Management
16th Jun 20106:15 pmRNSHolding(s) in Company
28th May 20102:56 pmRNSHolding(s) in Company
24th May 20104:25 pmRNSHolding(s) in Company
21st May 20105:04 pmRNSHolding(s) in Company
13th May 20107:00 amRNSHolding(s) in Company
4th May 20104:11 pmRNSHolding(s) in Company
4th May 20103:07 pmRNSTrading update
29th Apr 20109:49 amRNSHolding(s) in Company
29th Apr 20109:49 amRNSHolding(s) in Company
19th Apr 20101:30 pmRNSHolding(s) in Company
19th Feb 20102:56 pmRNSHolding(s) in Company
8th Feb 20107:00 amRNSDisposal
10th Nov 200911:21 amRNSHolding(s) in Company
15th Oct 20099:11 amRNSEnd of Offer Period
14th Oct 200910:46 amRNSRule 8.3- Care Capital Corp
5th Oct 20091:27 pmRNSRule 8.3- Care Capital Grp - Amendment
5th Oct 200912:54 pmRNSRule 8.3- Care Capital Corp
2nd Oct 200911:21 amRNSRule 8.3- CareCapital Group Plc
2nd Oct 200910:37 amRNSRule 8.3- (CareCapital Group Plc)
30th Sep 20093:35 pmRNSInterim Results
30th Sep 20093:26 pmRNSRule 8.3- CareCapital Group PLC
23rd Sep 20091:12 pmRNSRule 8.3- CareCapital Group Plc
23rd Sep 200911:24 amRNSRule 8.3- Carecapital Group
23rd Sep 20099:02 amRNSRule 8.3- Carecapital Group PLC
20th Aug 20091:15 pmRNSRule 8.3- Carecapital Group Plc
20th Aug 200910:40 amRNSRule 8.3- Carecapital PLC
19th Aug 20098:31 amRNSRule 8.3- CARECAPITAL GROUP PLC
18th Aug 20095:08 pmRNSHolding(s) in Company
17th Aug 20098:52 amRNSRule 8.3- CARECAPITAL GROUP PLC
12th Aug 20092:34 pmRNSHolding(s) in Company
12th Aug 20099:38 amRNSRule 8.3- Carecapital Group PLC
3rd Aug 20098:17 amRNSRule 8.3- CARECAPITAL GROUP PLC
31st Jul 20098:46 amRNSRule 8.3- CARECAPITAL GROUP PLC
30th Jul 20097:00 amRNSResult of AGM and Update re Possible Offer
30th Jun 20097:00 amRNSFinal Results
1st Jun 20093:10 pmRNSHolding(s) in Company
29th May 20094:25 pmRNSRule 8.3- CARECAPITAL GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.